According to seven bioinformatics algorithms (TIMER, CIBERSORT, CIBERSORT-ABS, QUANTISEQ, MCPCOUNTER, XCELL, and EPIC), we analyzed the relationship between MTA2 expression and clinical factors (gender, grade, age, ImmuneScore, ESTIMATEScore, N stage (Lymph Node), M stage (Metastasis), T stage (Tumor), and tumor AJCC stage) in immune-related cells in LIHC (Figure 17A). The gene discussed is MTA2; the disease is benign neoplasm.